Clearpath Health Network — Intelligence Profile

Health Score

3/10

Confidence high

The account data is consistent across all four sources — CRM notes, usage signals, support tickets, and email history all tell the same coherent story of a compliance-blocked, low-adoption account, providing a reliable basis for this assessment.

Account Narrative

Clearpath Health Network is critically under-adopted 5 months post-implementation, with only 2 of 22 seats active and 3 of 16 features in use. The primary blocker is a stalled BAA amendment in IT/legal review that has now been pending for approximately 3 months beyond the original 4-6 week estimate, effectively freezing broader staff provisioning. With renewal in roughly 7 months and no urgency expressed by the champion, this account carries significant churn risk if the compliance blocker is not resolved and adoption cannot be demonstrated before renewal conversations begin.

Key Signals

−

Only 2 of 22 provisioned seats active in last 30 days (9% activation rate) usage

−

Only 3 of 16 features ever used; workflow automation, analytics, and integrations entirely untouched usage

−

BAA amendment has been in IT/legal review for approximately 3 months, well past the original 6-8 week estimate provided by Kyle Marsh in February crm

−

Champion Dr. Foster is cooperative but expresses no urgency and has not escalated the IT blocker internally email

＋

CSM proactively offered to loop in legal and IT contacts to unblock BAA process email

∼

Support ticket requesting role-based access configuration suggests some intent to scale user provisioning when cleared support

∼

IT contact asked detailed technical questions about data residency and encryption, indicating active (if slow) review email

Expansion Opportunities

Full seat activation across remaining 20 unprovisioned users once BAA is resolved medium

Account contracted for 22 seats but only 2 are active; resolution of the compliance blocker could unlock the full user base and drive genuine platform adoption across clinical staff

Workflow automation and analytics dashboard adoption as a natural next step post-provisioning low

These features are untouched but were presumably part of the original purchase intent for a clinical ops team; a structured enablement push post-BAA could drive stickiness and upsell conversations

Risk Factors

Account may not renew at current contract value given near-zero demonstrated ROI at renewal high

2 of 22 seats active, 3 of 16 features used, logins declining, renewal in approximately 7 months — champion has no current reason to justify spend to leadership

BAA blocker is now significantly overdue with no clear resolution timeline or internal escalation from the customer side high

IT estimated 6-8 weeks in February 2024; it is now late May 2024, over 12 weeks later, with no update from Kyle Marsh or Dr. Foster

Champion disengagement — Dr. Foster is responsive but passive, forwarding materials without driving action medium

April 9 email confirms he acknowledged the adoption guide but deferred all action to IT clearance; no urgency expressed across any touchpoint

No executive sponsor or internal advocate beyond Dr. Foster identified, limiting ability to escalate the BAA process or create urgency medium

All CRM notes reference only Dr. Foster and IT contact Kyle Marsh; no C-suite or procurement relationship established

Continued login decline may signal even the 2 active users are losing engagement medium

Logins fell from 42 to 38 month-over-month despite CSM outreach; no new users added in recent months

Next Actions

CSM this week

Directly contact IT contact Kyle Marsh (not via Dr. Foster) to obtain a current status update on the BAA amendment review and offer to set up a joint call with your legal/compliance team to answer outstanding data residency and encryption questions

Leadership this month

Request a brief executive-level touchpoint with someone above Dr. Foster — ideally a CIO or VP of Operations — to surface the BAA delay as a business risk and create internal urgency on the IT side

CSM this month

Schedule a working session with Dr. Foster and the two active department heads to build a concrete provisioning and adoption plan that is ready to execute the moment BAA is cleared, so momentum is not lost

CSM this month

Begin internal renewal risk flagging and prepare a downgrade or churn scenario model; if BAA is not resolved by August 2024, escalate to Sales leadership for strategic account review

CSM monitor

Monitor login trend and active user count monthly; any further decline should trigger an immediate escalation review